WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013

Vaccine

Volumn 32, Issue 37, 2014, Pages 4713-4725

  Barr, Ian G ^a   Russell, Colin ^b   Besselaar, Terry G ^c   Cox, Nancy J ^d   Daniels, Rod S ^e   Donis, Ruben ^d   Engelhardt, Othmar G ^f   Grohmann, Gary ^g   Itamura, Shigeyuki ^h   Kelso, Anne ^a   McCauley, John ^e   Odagiri, Takato ^h   Schultz Cherry, Stacey ⁱ   Shu, Yuelong ^j   Smith, Derek ^b   Tashiro, Masato ^h   Wang, Dayan ^j   Webby, Richard ⁱ   Xu, Xiyan ^d   Ye, Zhiping ^k   Zhang, Wenqing ^c   more..

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^f NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^g THERAPEUTIC GOODS ADMINISTRATION   (Australia)

^h NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

ⁱ ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^j Chinese National Influenza Center (CNIC)   (China)

^k CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

more..

Author keywords

2013 2014; Human; Influenza; Northern Hemisphere; Quadrivalent; Recommendation; Trivalent; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ANTIGENICITY; EPIDEMIC; HUMAN; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; NONHUMAN; NORTHERN HEMISPHERE; NOTE; PRIORITY JOURNAL; VIRAL GENETICS; VIRUS DETECTION; VIRUS ISOLATION; WINTER; WORLD HEALTH ORGANIZATION; GENETICS; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA B VIRUS; INFLUENZA, HUMAN;

HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; WORLD HEALTH ORGANIZATION;

EID: 84905243382     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.02.014     Document Type: Note

References (9)

1. Recommended composition of influenza virus vaccines for use in the 2013 southern hemisphere influenza season. Weekly epidemiological record 2012; 87(41):389-400.
2. Matrosovich M., Matrosovich T., Carr J., Roberts N.A., Klenk H.D. Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J Virol 2003, 77(15):8418-8425.
3. Network WGIS Manual for the laboratory diagnosis and virological surveillance of influenza 2011, World Health Organization, Geneva, http://whqlibdoc.who.int/publications/2011/9789241548090_eng.pdf, [accessed 29.08.13]. W. Press (Ed.).
4. Guindon S., Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 2003, 52(Oct (5)):696-704.
5. Posada D., Crandall K.A. MODELTEST: testing the model of DNA substitution. Bioinformatics 1998, 14(9):817-818.
6. Zwickl D.J. Genetic algorithm approaches for the phylogenetic analysis of large biological sequence datasets under the maximum likelihood criterion 2006, Faculty of the Graduate School, University of Texas, [Ph.D. thesis].
7. Smith D.J., Lapedes A.S., de Jong J.C., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D., et al. Mapping the antigenic and genetic evolution of influenza virus. Science 2004, 305(July (5682)):371-376.
8. Barr I.G., McCauley J., Cox N., Daniels R., Engelhardt O.G., Fukuda K., et al. Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season. Vaccine 2010, 28(Feb (5)):1156-1167.
9. Lin Y.P., Gregory V., Collins P., Kloess J., Wharton S., Cattle N., et al. Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?. J Virol 2010, 84(July (13)):6769-6781.